Home/ economie ECONOMIEUS: Johnson & Johnson may acquire eye specialist for $3.4 billionPharmaceutical giant Johnson & Johnson is considering acquiring Ollin Biosciences, a biotech company specializing in eye diseases.Published 1h·1 sourceNotable Lire en françaisListen≈ 11sSpeed0.8×1×1.2×1.5×🔗Click the link to read an article on the topic:Financial Times↗🧭Explore this topicÉtats-UnisJohnson & JohnsonOllin Biosciences#Johnson & Johnson#rachat#biotechnologie#Ollin Biosciences#maladies oculairesWhat if you saw the whole news differently?Factae cross-checks hundreds of sources worldwide to keep only the fact, no opinion. Explore the front page.→États-Unis · © OpenStreetMap, OpenMapTiles, OpenFreeMapWorld map →Follow topic →↗ Share the newsAuto-synthesis from 1 media source · identified on November 16, 2026← Back to home